News and Views

Naproxen Improves Immune Response to Cancer in People With Lynch Syndrome

The nonsteroidal anti-inflammatory agent naproxen triggers immune cells in the intestinal lining to fight colorectal cancer in people with Lynch syndrome, researchers reported in Gut.

Trending Topics

View All Topics

FDA Grants Accelerated Approval to Dostarlimab-Gxly for dMMR Endometrial Cancer

Oncology Drug Research

FDA Grants Accelerated Approval to Dostarlimab-Gxly for dMMR Endometrial Cancer

FDA Announces Recall of BD Alaris Pump Module Model 8100 Because of Risk of Stuck or Unresponsive Keys

U.S. Food and Drug Administration (FDA)

FDA Announces Several New Recalls of BD Alaris Pump Module Model 8100 Because of Key and Bezel Problems

The Case of the Transgender Considerations for Cancer Screening

Patient Support

The Case of the Transgender Considerations for Cancer Screening

ONS Members See Beyond Barriers and Understand Benefits of Guidelines

ONS Members See Beyond Barriers and Understand Benefits of Guidelines

FDA Approves Nivolumab in Combination With Chemotherapy for Metastatic Gastric Cancer and Esophageal Adenocarcinoma

Clinical Practice

FDA Approves Nivolumab in Combination With Chemotherapy for Metastatic Gastric Cancer and Esophageal Adenocarcinoma

Meet Your ONS Leader: Teresa Knoop

Meet Your ONS Leader: Teresa Knoop

Surveys Show PPE Is Still in Short Supply

Personal Protective Equipment (PPE)

Surveys Show PPE Is Still in Short Supply

Betty Ferrell Receives 2021 ONS Lifetime Achievement Award

Betty Ferrell Receives 2021 ONS Lifetime Achievement Award

Onboarding and Supporting New Providers Are Your Responsibilities as an APRN Leader

Advanced Practice Nursing (APRN)

Onboarding and Supporting New Providers Are Your Responsibilities as an APRN Leader

FDA Grants Accelerated Approval to Sacituzumab Govitecan for Advanced Urothelial Cancer

Clinical Practice

FDA Grants Accelerated Approval to Sacituzumab Govitecan for Advanced Urothelial Cancer

Latina, Asian Women With Gynecologic Cancers Are Less Likely to Use Palliative Care

Latina, Asian Women With Gynecologic Cancers Are Less Likely to Use Palliative Care

Nursing Management of Adverse Events From Enfortumab Vedotin Therapy for Urothelial Cancer

Nursing Management of Adverse Events From Enfortumab Vedotin Therapy for Urothelial Cancer

Involve the Entire Cancer Care Team to Effectively Implement Guidelines

Clinical Practice Guidelines

Involve the Entire Cancer Care Team to Effectively Implement Guidelines

The Case of the Targeted Therapy Toxicity

Genetics & Genomics

The Case of the Targeted Therapy Toxicity

Nursing Considerations for Head and Neck Cancer Survivorship Care

Nursing Considerations for Head and Neck Cancer Survivorship Care

FDA Approves Sacituzumab Govitecan for Triple-Negative Breast Cancer

Clinical Practice

FDA Approves Sacituzumab Govitecan for Triple-Negative Breast Cancer

Adding MRI to PSA Detects More Prostate Cancers Than PSA Alone

Adding MRI to PSA Detects More Prostate Cancers Than PSA Alone

FDA Approves New Cetuximab Dosing Regimen for Colorectal Cancer and Squamous Cell Carcinoma

U.S. Food and Drug Administration (FDA)

FDA Approves New Cetuximab Dosing Regimen for Colorectal Cancer and Squamous Cell Carcinoma

FDA Issues Safety Communication for ADM Products Used in Implant-Based Breast Reconstruction

Clinical Practice

FDA Issues Safety Communication for ADM Products Used in Implant-Based Breast Reconstruction

New Guidelines in Cancer Care: How Nurses Have Implemented Them to Transform Practice

Clinical Practice Guidelines

New Guidelines in Cancer Care

Protecting Nurses and Patients and Advancing Practice Drive ONS Advocacy

Protecting Nurses and Patients and Advancing Practice Drive ONS Advocacy

In Case You Missed It: Here Are the Big ONS Changes in Recent Years

In Case You Missed It: Here Are the Big ONS Changes in Recent Years

FDA Approves Isatuximab-Irfc for Multiple Myeloma

U.S. Food and Drug Administration (FDA)

FDA Approves Isatuximab-Irfc for Multiple Myeloma

Muscle Quality Predicts Efficacy of NSCLC Immunotherapy

Muscle Quality Predicts Efficacy of NSCLC Immunotherapy

Oncology Drug Reference Sheet: Decitabine and Cedazuridine

Cancer Treatments

Oncology Drug Reference Sheet: Decitabine and Cedazuridine

FDA Approves Idecabtagene Vicleucel as the First Cell-Based Gene Therapy for Adult Patients With Multiple Myeloma

Clinical Practice

FDA Approves Idecabtagene Vicleucel as the First Cell-Based Gene Therapy for Adult Patients With Multiple Myeloma

Zydus Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Acyclovir Sodium Injection

Clinical Practice

Zydus Pharmaceuticals Inc. Issues Voluntary Nationwide Recall of Acyclovir Sodium Injection

Infection Prevention for Oncology Nurses

Clinical Practice

Infection Prevention for Oncology Nurses

Research Validates Tools to Increase Screening in Communities of Color

Cancer Research

Research Validates Tools to Increase Screening in Communities of Color

Diabetes May Increase Hematologic Cancer Risk and Mortality

Cancer Risk Prevention

Diabetes May Increase Hematologic Cancer Risk and Mortality

All Patients, Regardless of Insurance, Must Have Access to Cancer Screening

Cancer Screening

All Patients, Regardless of Insurance, Must Have Access to Cancer Screening

Genetic Disorder Reference Sheet: CHEK2 Gene Pathogenic Variants

Genetics & Genomics

Genetic Disorder Reference Sheet: CHEK2 Gene Pathogenic Variants

FDA Approves Pembrolizumab for Esophageal or GEJ Carcinoma

U.S. Food and Drug Administration (FDA)

FDA Approves Pembrolizumab for Esophageal or GEJ Carcinoma

FDA Advises Healthcare Professionals Not to Use BD’s ChloraPrep™ 3 ml Applicators

U.S. Food and Drug Administration (FDA)

FDA Advises Healthcare Professionals Not to Use BD’s ChloraPrep™ 3 ml Applicators

Meet Your ONS Leader: Susie Maloney-Newton

Meet Your ONS Leader: Susie Maloney-Newton

Fear of Recurrence May Actually Contribute to Cancer Recurrence

Cancer Recurrence

Fear of Recurrence May Actually Contribute to Cancer Recurrence

Don’t Get Trapped in the Pitfalls of Perfectionism

Nurse Well-Being

Don’t Get Trapped in the Pitfalls of Perfectionism

What the Evidence Says About Music Therapy for Cancer-Related Fatigue?

Symptom Management

What the Evidence Says About Music Therapy for Cancer-Related Fatigue

Management Strategies for Cutaneous Toxicity From EGFR Inhibitors

Advanced Practice Nursing (APRN)

Management Strategies for Cutaneous Toxicity From EGFR Inhibitors

$FDA Approves Tivozanib for Relapsed or Refractory Advanced Renal Cell Carcinoma$

Oncology Drug Research

FDA Approves Tivozanib for Relapsed or Refractory Advanced Renal Cell Carcinoma

Lung Cancer Screening Guidelines to Reduce Disparities May Increase Them Instead—But Risk Model Can Help

Cancer Screening

Lung Cancer Screening Guidelines to Reduce Disparities May Increase Them Instead—But Risk Model Can Help

Manage Adverse Events From PI3K Inhibitors for Breast Cancer

Manage Adverse Events From PI3K Inhibitors for Breast Cancer

$FDA Grants Accelerated Approval to Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma$

U.S. Food and Drug Administration (FDA)

FDA Grants Accelerated Approval to Axicabtagene Ciloleucel for Relapsed or Refractory Follicular Lymphoma

Leadership Survey Identifies Areas for Chapter Support

Leadership Survey Identifies Areas for Chapter Support

Nurse Scientists Guide the Evidence in Symptom Science, and Inaugural Colloquium Recognizes That Impact on a National Level

Oncology Nurse Researcher

Nurse Scientists Guide the Evidence in Symptom Science, and Inaugural Colloquium Recognizes That Impact on a National Level

FDA Approves Lorlatinib for ALK-Positive Metastatic NSCLC

FDA Approves Lorlatinib for ALK-Positive Metastatic NSCLC

Nursing Considerations for Colorectal Cancer Survivorship Care

Survivorship Care Plans

Nursing Considerations for Colorectal Cancer Survivorship Care

U.S. Sees Another Record-Breaking Decrease in Cancer Deaths, but Disparities Remain

Cancer Research

U.S. Sees Another Record-Breaking Decrease in Cancer Deaths, but Disparities Remain

Patient Education Reduces Barriers and Increases Adherence Rates

Patient Education

Patient Education Reduces Barriers and Increases Adherence Rates

Back to Top ▲